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ABSTRACT
Uniquely among RNA viruses, replication of the
 30-kb SARS-coronavirus genome is believed to
involve two RNA-dependent RNA polymerase
(RdRp) activities. The first is primer-dependent and
associated with the 106-kDa non-structural protein
12 (nsp12), whereas the second is catalysed by the
22-kDa nsp8. This latter enzyme is capable of de
novo initiation and has been proposed to operate
as a primase. Interestingly, this protein has only
been crystallized together with the 10-kDa nsp7,
forming a hexadecameric, dsRNA-encircling ring
structure [i.e. nsp(7+8), consisting of 8 copies of
both nsps]. To better understand the implications
of these structural characteristics for nsp8-driven
RNA synthesis, we studied the prerequisites for
the formation of the nsp(7+8) complex and its poly-
merase activity. We found that in particular the
exposure of nsp8’s natural N-terminal residue was
paramount for both the protein’s ability to associate
with nsp7 and for boosting its RdRp activity.
Moreover, this ‘improved’ recombinant nsp8 was
capable of extending primed RNA templates, a
property that had gone unnoticed thus far. The
latter activity is, however,  20-fold weaker than
that of the primer-dependent nsp12-RdRp at equal
monomer concentrations. Finally, site-directed mu-
tagenesis of conserved D/ExD/E motifs was
employed to identify residues crucial for nsp(7+8)
RdRp activity.
INTRODUCTION
In the replicative cycle of RNA viruses, the crucially im-
portant process of RNA-templated RNA synthesis is
generally performed by an RNA-synthesizing complex of
viral enzymes (1,2). Commonly, its core subunit is a single
RNA-dependent RNA polymerase (RdRp) that drives the
production of template strands for replication, new
genome molecules, and—in many RNA virus groups—
also subgenomic (sg) mRNAs. This canonical RdRp is
structurally conserved among RNA viruses and widely
accepted to drive catalysis of phosphodiester bond forma-
tion via a well-established reaction mechanism involving
two metal ions that are coordinated by aspartate residues
in its motifs A and C (3–5).
Uniquely among RNA viruses, however, current
evidence suggests that at least two RdRp activities are
encoded by the genomes of members of the coronavirus
(CoV) family, the+RNA virus group that infects a wide
range of vertebrates and is renowned for its exceptionally
large polycistronic genome of  30 kilobases (6). Both
CoV RdRps belong to the set of 16 non-structural
proteins (nsps) that are produced through proteolytic pro-
cessing of the pp1a and pp1ab replicase precursor
polyproteins, which both derive from translation of the
genomic RNA (7,8). For the Severe Acute Respiratory
Syndrome-associated coronavirus (SARS-CoV), which
emerged in 2003 and caused worldwide concern due to
the  10% mortality rate associated with infection of
humans (6,9), the two replicase subunits with RdRp
activity have been studied in some detail. The ﬁrst is the
106-kDa nsp12, which contains the canonical viral RdRp
motifs in its C-terminal part and employs a primer-
dependent initiation mechanism (10,11). The second poly-
merase, the 22-kDa nsp8, is unique for CoVs and was
reported to be only capable of de novo RNA synthesis
with a low ﬁdelity on ssRNA templates (12). Together,
these observations inspired a hypothesis in which nsp8
would serve as an RNA primase, i.e. would synthesise
short oligonucleotide primers for subsequent extension
by the nsp12 ‘main RdRp’ (12).
In spite of this attractive model, however, many ques-
tions regarding CoV RNA synthesis remain unanswered
*To whom correspondence should be addressed. Tel: +31 71 5261657; Fax: +31 71 5266761; Email: e.j.snijder@lumc.nl
Present address:
Sjoerd H. E. van den Worm, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.
Published online 29 October 2011 Nucleic Acids Research, 2012, Vol. 40, No. 4 1737–1747
doi:10.1093/nar/gkr893
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.thus far. For instance, it is unclear whether the homomeric
form of nsp8, for which in vitro RdRp activity was previ-
ously documented (12), actually occurs in vivo, as nsp8
was also shown to co-crystallize and form a unique
hexadecameric ring-structure with the 10-kDa nsp7
subunit that resides immediately upstream in the replicase
polyprotein precursors (Figure 1) (13). In a similar
fashion, it is presently unknown whether the postulated
double-stranded RNA (dsRNA) binding channel of this
complex plays a role in the RdRp activity of nsp8 and
whether this activity is inﬂuenced by nsp7, particularly
given the observed low ﬁdelity and low processivity of
nsp8 (12).
To investigate the properties of the nsp7+nsp8
[nsp(7+8)] hexadecamer in more detail, and seek answers
to the above questions, we here generated and puriﬁed
recombinant forms of SARS-CoV nsp8 and nsp(7+8)
that have natural N-terminal residues. This technical re-
ﬁnement was found to greatly improve nsp8’s ability
to associate with nsp7. Moreover, and in contrast to
previous observations (12), exposure of the natural
N-terminus proved crucial for the enzymatic activity of
the complex on partially double-stranded RNA templates,
demonstrating that nsp(7+8) is capable of primer-
dependent RdRp activity as well. Site-directed mutagen-
esis of nsp8 in the context of the nsp(7+8) complex
identiﬁed a conserved D/ExD/E motif that is important
for catalysis in vitro, possibly providing a ﬁrst indication
of the location of the presently unknown nsp8 active site.
Overall, these results deﬁne the SARS-CoV nsp(7+8)
complex as an intriguing multimeric RNA polymerase
that is capable of primer extension.
MATERIALS AND METHODS
Cloning, mutagenesis and expression
For SARS-CoV nsp7–nsp8 expression, the sequence
encoding amino acids 3837-4117 of the SARS-CoV replic-
ase pp1a was ampliﬁed by reverse transcription-
polymerase chain reaction (RT-PCR) from the genome
of SARS-CoV isolate Frankfurt-1 (Genbank accession
number AY291315). The primers used were SAV704 and
SAV429 (Supplementary Table S1). For nsp8 expression,
the sequence encoding pp1a residues 3920 to 4117 was
ampliﬁed by RT-PCR using SAV428 and SAV429 as
primers (Supplementary Table S1). Both PCR products
were digested with SacII and BamHI, and ligated into
expression vector pASK3-Ub-CHis6 (10). This vector
was originally derived from the pET26-Ub-CHis6 vector
(14), but drives expression of N-terminally ubiquitin-
tagged and C-terminally His6-tagged fusion proteins via
a tetracyclin-inducible promoter, to rule out the potential
T7 polymerase contaminations that are known to cause
false positive results when using T7 promoter-driven
systems for recombinant RdRp expression. All described
nsp8 mutants were engineered via site-directed mutagen-
esis according to the QuikChange protocol (Stratagene)
using the primers listed in Supplementary Table S2.
For nsp7-8 or nsp8 expression, Escherichia coli C2523
cells (New England Biolabs) were transformed with the
plasmids pASK3-Ub-nsp7-8-CHis6 or pASK3-Ub-nsp8-
CHis6 together with the Ubp1 protease expression
plasmid pCG1 (14). Routinely, 50ml of Luria Broth, con-
taining ampicillin (50mg/ml) and chloramphenicol
(34mg/ml), was inoculated 1:1000 with o/n precultures,
and cells were grown to OD600 >0.8 at 37 C.
Subsequently, the cells were slowly cooled to 20 C,
followed by induction with anhydrotetracycline (Fluka)
at a ﬁnal concentration of 200ng/ml for 16h. Expression
at 20 C was, however, only crucial for the preparation of
certain nsp8 mutants and similar yields of active wild-type
protein could be obtained by expression at 37 C for 3–4h.
Cells were harvested by centrifugation and stored at 20 C
until protein puriﬁcation was started.
The expression of SARS-CoV nsp7 with a C-terminal
His6-tag (nsp7-His) was achieved from plasmid
pDEST14-nsp7-His6 according to the protocol previously
described for EAV nsp9 (11). SARS-CoV nsp5-His6
(nsp5-His) was expressed as a self-cleaving maltose
binding protein (MBP)-fusion protein and was puriﬁed
via its C-terminal His6-tag (15). The pASK3-His-nsp8
plasmid for expression of the N-terminally His6-tagged
Figure 1. SARS-coronavirus genome organization and structure of the
nsp7+nsp8 hexadecamer. (A) The coronavirus genome contains two
large 50-proximal ORFs (ORF1a and 1 b) that encode the two replicase
polyproteins, whose mature products assemble into the viral replication
and transcription complex. Both polyproteins are cleaved (cleavage sites
indicated with arrow heads) by the proteinase activities of nsp3 (black
lines) and nsp5 (red lines), which releases the mature nsps. Also
indicated are the 50 cap structure and the 30 polyA tail (An). (B) The
SARS-CoV nsp8 crystal structure (pdb 2AHM) resembles a ‘golf
club-like’ shape, as presented by the yellow ribbon structure. This
nsp8 conformation connects to a much larger, hexadecameric structure
that is composed of seven additional nsp8 subunits (grey) and eight
nsp7 subunits (green). The hollow hexadecameric ring structure has a
positively charged channel (blue background shading) that was
proposed to mediate RNA binding. The outside of the structure is
predominantly negatively charged (red background shading).
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(University of Marseille, France).
Puriﬁcation of SARS-CoV nsp8, nsp7-8 and nsp7
Bacterial pellets were thawed on ice, resuspended in buffer
A [20 mM HEPES pH 7.4, 10mM imidazole, 0.05%
Tween-20, 5mM b-mercaptoethanol and EDTA-free
protease inhibitor cocktail (Roche)] containing 500mM
NaCl, and lysed by sonication. The supernatant was
cleared by ultracentrifugation at 20000g for 30min and
subsequently incubated with Talon beads (Clontech) for
2h at 4 C. The beads were washed four times 15min with
20 volumes of binding buffer. Ultimately, the C-terminally
His6-tagged proteins were eluted with 150mM imidazole
in buffer A containing 150mM NaCl, or cleaved off of the
column during a 3-h digestion with SARS-CoV nsp5 in
the presence of 4mM MgCl2.
The eluates were analysed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS–PAGE) and typ-
ically found to be >90% pure. Elution fractions contain-
ing nsp8-, nsp7-8 or nsp7 were subsequently pooled,
dialysed, stored and analysed as described previously for
SARS-CoV nsp12 (10).
Chemical cross-linking
To study SARS-CoV nsp(7+8) complex formation, differ-
ent nsp8:nsp7 ratios were mixed in binding buffer (20mM
HEPES pH 7.5, 50mM NaCl, 5% glycerol, 0.1% Triton
X-100 and 1mM DTT) to give a ﬁnal reaction volume
of 10ml. The proteins were pre-incubated for 10min at
20 C, after which cross-linking was initiated through
the addition of 0.5ml of a freshly prepared 2.5%
glutaraldehyde solution. The reactions were incubated
for a further 5min at 30 C and then terminated with
1ml 1M Tris pH 8.0. Analysis of complex formation was
performed on SDS–PAGE gels, which were stained with
Coomassie G-250 dye.
Template binding assays
A dilution series of 0–5mM SARS-CoV nsp8 in storage
buffer was incubated for 10min at 20 C with 0.2nM of
32P-labelled duplex RNA. Subsequently, samples were
directly loaded onto 8% polyacrylamide gels containing
5% glycerol and 0.5x TGE (25mM Tris, 190mM glycine
and 10mM EDTA) buffer and run at 150V for 1h at 4 C.
Gels were dried on Whatman ﬁlter paper and bands were
quantiﬁed by phosphorimaging using a Typhoon variable
mode scanner (GE Healthcare) and ImageQuant TL 7.0
software (GE Healthcare) as described elsewhere (10).
Using the Matlab 2009a Curve Fitting Toolbox, the per-
centage of bound RNA was ﬁt to the Hill equation, which
is deﬁned as: RNAbound ¼ b  ½ nsp8 
n=ðKn
d+½nsp8 
nÞ. Here b
is the upper binding limit, ½nsp8  the nsp8 concentration, n
the Hill coefﬁcient and Kd the dissociation constant.
Polymerase activity assays
The oligoribonucleotide substrates used for polymerase
assays are listed in Table 1 and were prepared as described
previously (10). Primer-extension assays for nsp8, the
nsp7-8 polyprotein, and the nsp(7+8) complex were essen-
tially performed as described previously for SARS-CoV
nsp12 (10,11). In each primer-extension reaction, typically
1mM wild-type or mutant nsp8 was incubated with 4mM
MgCl2,5 0 mM GTP, 50mM ATP, 0.17mM[ a-
32P]ATP,
1mM DTT, 0.1% Triton X-100, 10mM KCl and
20mM Tris (pH 9.5). At most, 10mM NaCl and 5%
glycerol were introduced with the nsp8 storage buffer.
Gels were run and analysed as described previously (10).
To convert the phosphorimager signal into the amount of
[a-
32P]AMP incorporated, a 10
 2 to 10
 5 dilution series of
the [a-
32P]ATP stock was spotted in triplicate on
Whatman ﬁlter paper and exposed alongside the PAGE
gel. The amount of incorporated label was ultimately cor-
rected for the concentration of competing, unlabelled nu-
cleotides present in the reaction mixture.
De novo initiation assays were essentially performed as
described by Imbert et al. (12), with small modiﬁcations
for optimisation. Brieﬂy, 1mM wild-type or mutant
nsp8 was incubated with 4mM MgCl2, 1mM MnCl2,
1mM GTP, 5mM ATP, 0.17mM[ a-
32P]ATP and 1mM
of oligo AFMB131.
Sequence alignment
Alignments of nsp8 sequences were made using Muscle
(16). Sequences used included the alphacoronaviruses
human CoV 229E (NC_002645), human CoV NL63
(NC_005831), and bat CoV HKU8 (NC_010438); the
betacoronaviruses SARS-CoV Frankfurt-1 (AY291315),
mouse hepatitis virus A59 (MHV, NC_001849) and
human CoV OC43 (NC_005147); and the gammacoro-
naviruses beluga whale CoV SW1 (NC010646), turkey
CoV (NC_010800) and avian infectious bronchitis virus
(IBV, AJ311317).
RESULTS
N-terminal processing deﬁnes nsp8 multimerization and
nsp(7+8) complex formation
SARS-CoV nsp7 and nsp8 were previously reported to
interact and form a hollow ring structure that is
composed of an intricate nsp8 octamer supported by
Table 1. Oligoribonucleotides used for activity assays
RNA oligo Purpose Sequence
SAV555 (UC)10 template 5’-UUUUUUUUUUUUUUUUUUUUAUAACUUAAUCUCACAUAGC-3’
SAV556 (U)20 template 5’-UCUCUCUCUCUCUCUCUCUCAUAACUUAAUCUCACAUAGC-3’
SAV557 primer 5’-GCUAUGUGAGAUUAAGUUAU-3’
AFMB131 de novo assay template 5’-UAUAAUCCAAAA-3’
Nucleic Acids Research,2012, Vol.40, No. 4 1739eight copies of nsp7 (13,17) (Figure 1B). Based on the
large diameter, positive charge of the hexadecamer’s
channel and in silico docking, it was proposed to be able
to encircle dsRNA (Figure 1B). However, the functional
signiﬁcance of the compound interactions between nsp7
and nsp8 is poorly understood, as are the polymerase
activities associated with monomeric nsp8 or
nsp8-containing multimers. So far, strategies for the puri-
ﬁcation of recombinant nsp8 have involved the use of
afﬁnity tags [e.g. His6 or glutathione-S-transferase (GST)
(12,13)] that were fused to one terminus to facilitate
protein recovery. Inadvertently though, such tags or
other exogenous sequences may signiﬁcantly impede the
correct folding of enzymes and thus alter their stability or
activity, as exempliﬁed by studies of the poliovirus (3D
pol)
and SARS-CoV (nsp12) RdRp subunits (10,14,18). To
circumvent this issue, we developed a protocol in which
SARS-CoV nsp8 was expressed as a ubiquitin (ub) fusion
protein carrying a C-terminal His6-tag (ub-nsp8-His),
which was subsequently processed at both termini in two
steps. The ﬁrst step was co-translational and involved the
release of the N-terminal ub fusion partner by the
co-expressed ubiquitin carboxyl-terminal hydrolase 1
(Upb1, Figure 2A) (10,14). The second proteolytic step,
catalysed by a recombinant form of the SARS-CoV nsp5
main protease (15), removed the C-terminal His6-tag and
was performed either in solution (Figure 2A and B) or
when nsp8-His was immobilised to Talon beads. This pro-
cedure yielded SARS-CoV nsp8 with its exact natural N-
and C-terminus (replicase residues Ala-3920 and
Gln-4117, respectively; Figure 2A), the product that is
normally liberated by the nsp5-driven autoprocessing of
the SARS-CoV replicase polyproteins (19).
In accordance with the octameric state observed in
cross-linking experiments using glutaraldehyde
(Supplementary Figure S1) or ethylene glycolbis (13), the
hydrodynamic proﬁle of the untagged nsp8 corresponded
to a mass of  160kDa (Figure 2D). To identify and
explain differences with previously published observa-
tions, we also produced and characterised N- and
C-terminally tagged forms of nsp8 (Figure 2C).
Importantly, under the same assay conditions, the
N-terminally His6-tagged nsp8 (His-nsp8) that was used
in the original nsp8 RdRp activity study (12) showed a
marked difference in multimerization behaviour
(Figure 2D and Supplementary Figure S1). On the other
hand, little difference was observed between untagged
nsp8 and a C-terminally His6-tagged version of the
protein (nsp8-His; Figure 2E).
To investigate whether nsp7 could inﬂuence the change
in multimerisation behaviour, we next added separately
puriﬁed and C-terminally processed nsp7 to the different
nsp8 preparations. Interestingly, we found that nsp8 and
nsp8-His could both associate with this protein, in accord-
ance with published data (13), but that His-nsp8 was
unable to do so within the frame of our experimental con-
ditions (Figure 2F). Consequently, although various lines
of evidence support the observation that nsp7 and nsp8
can form a hexadecamer, it now appears that the correct
N-terminal processing of nsp8 is a signiﬁcant factor in
determining the ﬁnal oligomeric state of the protein.
SARS-CoV nsp7 enhances RNA binding by nsp8
A unique feature of the hexadecameric SARS-CoV
nsp(7+8) structure is the fact that it does not derive
from stacking of its protein subunits, but rather from
stable inter-connections of the ‘golf club-like’ nsp8 mol-
ecules (Figure 1B) (13). The structural support of the nsp8
Figure 2. Puriﬁcation and multimerization of recombinant SARS-CoV
nsp7-8 precursor and different nsp8 variants. (A) Expression of nsp8 in
the presence of the ubiquitin protease Ubp1 to liberate the natural
N-terminal sequence (AIASEF), followed by puriﬁcation and cleavage
by recombinant SARS-CoV nsp5 main protease to remove the
C-terminal His6-tag and its upstream GSSG linker. (B) Eighteen
percent SDS-PAGE analysis of nsp5-treated, puriﬁed nsp8-His demon-
strates near-complete release of the C-terminal His6-tag within 60min.
The maltose binding protein (MBP) was added to the reaction to serve
as an independent loading control. Asterisks indicate non-speciﬁc
bands. (C) In addition to the tag-less nps8 and nsp8-His, we also
produced the N-terminally His6-tagged nsp8 (His-nsp8) used by
Imbert et al. (12). (D) Comparative gel ﬁltration analysis of nsp8
(22kDa as a monomer) versus His-nsp8 and (E) nsp8 versus
nsp8-His. In all three cases, nsp8 formed multimers in solution, but
the apparent molecular mass of complexes formed by both nsp8 and
nsp8-His was  2-fold higher than for complexes formed by His-nsp8.
(F) Comparative analysis of nsp8, nsp(7+8), His-nsp8 and
nsp7+nsp8-His. Only nsp(7+8) showed a molecular weight shift to
the  225-kDa size range with a standard deviation of 15-kDa
(n=3). This size is indicative of hexadecamer formation, whereas the
analysis of nsp7+nsp8-His showed dominant peaks of nsp8-His and
nsp7 (which is  10kDa as a monomer).
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dant, in line with the critical role for the nsp8 N-terminal
domain described above. We surmised therefore that the
additional complexity must have evolved to improve
nsp8’s function and set out to compare the RNA
binding capabilities of the puriﬁed nsp8 octamer and
nsp(7+8) hexadecamer.
By analysing the steady-state ribonucleotide-protein
(RNP) complexes formed through binding of nsp8 to 50
32P-labelled dsRNA (Figure 3A), we estimated the nsp8
dissociation constant (Kd) for dsRNA to be  3.3mM
(Figure 3F), which is about  25-fold higher than the
apparent Kd of nsp12 under comparable conditions
(10). A comprehensive analysis of the inﬂuence of nsp7
on nsp8-dependent RNA binding required an nsp8
mutant that was incapable of RNA binding. To this
end, we engineered an alanine substitution of the
conserved residue K58, which resides in nsp8’s
proposed dsRNA-binding channel [residues 55–78 (13)].
As is evident from the electromobility shift assay in
Figure 3B, this mutation was sufﬁcient to signiﬁcantly
disrupt RNA binding. As a control, we also performed
an aspartate-to-alanine substitution at position 52,
which is partially conserved, yet not expected to partici-
pate in RNA backbone binding due to its negative
charge and position just outside the proposed RNA
binding channel. Indeed, the D52A mutation only
induced a migratory shift of the dominant RNP signal
towards the anode, likely as a result of the lost negative
charge (Figure 3C).
With the results obtained with these control proteins in
mind, we next explored the contribution of nsp7 to RNA
binding by the nsp(7+8) complex. We used a ﬁxed concen-
tration of nsp7 and added either wild-type or mutant nsp8
up to the point where the nsp7:nsp8 ratio reached
equimolarity. No RNA binding was observed in the
absence of nsp8, but upon nsp(7+8) complex formation
the amount of bound dsRNA rapidly increased
(Figure 3D). Indicative of successful complex formation,
we also observed a shift in the molecular weight of the
major RNP complex formed (Figure 3D). Western blot
analysis conﬁrmed that both nsp7 and nsp8 were present
at this position in the gel (not shown), but due to the
generally unpredictable migration behaviour of proteins
and RNPs in native PAGE, it was not possible to assess
whether this band indeed corresponded to the nsp(7+8)
hexadecamer. The Kd of the nsp(7+8) complex was
estimated at  1.2mM, about 3-fold lower than that of
nsp8 alone (Figure 3F).
When we next added an equimolar amount of nsp7 to
the nsp8 RNA-binding mutant K58A, we observed a
minor increase in the binding afﬁnity for RNA
(compare Figure 3B with 3E). Mutant D52A, on the
other hand, behaved similar to the wild-type protein
(Figure 3E). Together, these results complement the ob-
servation that various positively charged nsp7 residues
line the inside of the nsp8-scaffolded RNA binding
channel (13), and they provide the ﬁrst direct evidence
for a functional role of nsp7 in the SARS-CoV
nsp(7+8) structure.
Figure 3. SARS-CoV nsp7 stimulates nsp8-dependent RNA binding.
(A) Five prime
32P-labelled dsRNA was incubated with increasing con-
centrations (0–5mM) of wild-type nsp8, (B) nsp8 K58A, (C) or nsp8
D52A. Clearly, mutation of K58 to alanine signiﬁcantly reduced the
binding afﬁnity of nsp8, whereas mutation of D52 to alanine did not.
We also noted that the change in charge due to the mutation (up to
8-fold in the octamer) resulted in an upward shift of the dominant RNP
band, relative to the dominant RNP in panel 3A (labelled with
black 1). (D) Five prime
32P-labelled duplex RNA was incubated
with a ﬁxed concentration of nsp7 (5mM) and increasing concentrations
of wild-type nsp8 (0-5mM). Note the migration shift of the dominant
ribonucleotide-protein (RNP) complex in the presence of nsp7
(compare RNPs labelled with black 1 and grey 2). (E) Addition of an
equimolar amount of nsp7 to the nsp8 mutants D52A and K58A
stimulated binding of dsRNA. For reference, the 2:1 and 1:1 ratios
of wild-type nsp8 and nsp7 are shown in the left panel. Asterisks
indicate non-speciﬁc bands. (F) RNA-binding curves for nsp8 in the
absence (grey triangles) or presence of a ﬁxed (5mM) concentration
of nsp7 (black circles). Lines represent ﬁts to the Hill equation, while
error bars represent standard deviations (n=3).
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Given nsp(7+8)’s ability to bind dsRNA, we wondered
whether this protein complex would also be catalytically
active on this type of template and able to incorporate
nucleoside monophosphates (NMPs) into partially
double-stranded RNA molecules, i.e. primed templates.
We therefore examined the ability of nsp8 to extend a
20-nt primer that was pre-annealed to a heteromeric
template with relatively low secondary structure, to rule
out potential adverse effects of hairpins (Figure 4A).
Interestingly and in contrast to previous observations
(12), the nsp(7+8) complex readily extended the primer
up to template length, resulting in the formation of a
40-base pair RNA duplex (Figure 4B).
The negatively charged and helical polymer heparin is
able to occupy the binding sites of RNA and DNA poly-
merases, and can thus directly compete with RNA and
DNA templates. To verify that the full-length and
longer RNA products were derived from single nsp(7+8)
complexes bound to the template (i.e. from a processive
activity), and not from multiple binding and extension
events (i.e. a distributive activity), we performed the
primer extension reaction in the presence of heparin to
trap any unbound nsp(7+8). We ﬁrst tested the concentra-
tion required to saturate all nsp(7+8) complexes in the
reaction by titrating 0–100mM into the reaction
(Supplementary Figure S2A) and observed that the incorp-
oration levels were stable above 1mM (Supplementary
Figure S2B), suggesting that these reactions represent
single initiation–extension events. We next assessed
whether the activity of nsp8 or nsp(7+8) was distributive
or processive by quantifying the incorporated signal in
full-length or longer products in the presence of 1mM
heparin (Figure 4C). As shown in Figure 4D, 66±4%
(mean±standard deviation) of the nsp8 products were
full length compared to 61±2% of the nsp(7+8)
products, suggesting that both the enzymes complexes
are mostly processive and that nsp7 does not confer add-
itional processivity to nsp8. Interestingly, both nsp8 and
nsp(7+8) are able to extend the RNA primers beyond
template length in the presence of heparin (Figure 4D
and Supplementary Figure S2B), suggesting that these ex-
tensions result from terminal transferase activity and not
from template switching, as was previously observed for
poliovirus 3D
pol (20).
The nsp(7+8) complex requires a D/ExD/E motif for
catalysis
Intrigued by the primer extension activity of the
SARS-CoV nsp(7+8) complex described above, we next
designed a set of mutations to verify that the activity
indeed was nsp(7+8) derived and to identify the most
critical residues for activity in the complex. We ﬁrst
tested RNA-binding mutant K58A (Figure 2) at varying
concentrations and observed a  95% loss of nucleotide
incorporation activity compared to the wild-type protein
(Figure 5). Other likely candidates for a direct role in
RdRp catalysis generally are Mg
2+-coordinating aspartate
residues and lysine or histidine residues that can function
as general acid (3). In canonical RNA polymerases, the
aspartates commonly reside in motifs A and C (3,21),
while in DNA-dependent RNA primases they are
usually found in a central D/ExD/E motif (22). Given
the absence of classical RdRp A and C motifs in the
nsp8 sequence (12), we screened an alignment of CoV
nsp8 sequences for conserved D/ExD/E motifs.
Interestingly, we found such a motif in both the
N-terminal and the C-terminal domain (Figure 5A).
Subsequent alanine substitution of the N-terminal D/
ExD/E motif, composed of D50 and D52 in SARS-CoV,
greatly affected primer extension activity on the CU10
template as shown in Figure 5C. Mutation of the down-
stream domain (residues D161 and D163 in SARS-CoV),
however, had a much smaller effect on polymerase
activity, suggesting that this C-terminal D/ExD/E motif
is not critical for catalysis. Controls included mutant
K58A and a mutant carrying a lysine-to-alanine substitu-
tion of the non-conserved residue 127. In line with the
observation of the U20 template and its conservation in
CoVs, the loss of a lysine at position 58 resulted in a near
complete loss of RdRp activity, whereas mutation of K127
positively inﬂuenced RNA synthesis (Figure 5).
Figure 4. The nsp(7+8) complex has primer extension activity.
(A) Schematic presentation of the nsp8 primer extension assay, in
which [a-
32P]AMP and GMP are incorporated into a primed RNA
template. In the ﬁgure, the initial RNA duplex is coloured red, the
(UC)10 template region blue and the newly incorporated nucleotides
grey. (B) Incorporation of [a-
32P]AMP by the nsp(7+8) complex.
Samples were taken at the indicated time points and resolved on a
20% PAGE/7M urea gel. (C) Schematic presentation of the single-cycle
reaction. Template and nsp(7+8) complex were pre-incubated for
10min before nucleotides were added. The mixture was then rapidly
split into equal aliquots that were immediately mixed with heparin to
trap unbound or released enzyme. (D) Samples were taken after 60min
and resolved on 20% PAGE/7M Urea.
1742 Nucleic Acids Research, 2012,Vol.40, No. 4Inﬂuence of divalent ions and protons on nsp(7+8) activity
As outlined above, magnesium ions are well-known
cofactors of nucleic acid polymerases and assist in the co-
ordination and activation of incoming nucleoside triphos-
phates. Also the activity of SARS-CoV nsp(7+8) was
found to be positively correlated with the Mg
2+ concen-
tration, albeit with a broad optimum running from
4–10mM (Figure 6A). At this optimum, nsp(7+8) incorp-
orates  1mM NMP into the primed template permMo f
monomeric nsp7 and nsp8 present in the reaction.
Similar to the presence of divalent cations, the pH
greatly affects the activity of RdRps and has been
shown to play a role in both catalysis and ﬁdelity (3,23).
To investigate the inﬂuence of the pH on nsp(7+8),
we tested the activity of the complex in a pH range of
6–11. As shown in Figure 6C, we observed a sharp
optimum at pH 9.5, which is considerably higher than
the optimum that was previously observed for the
SARS-CoV nsp12-RdRp and the His-nsp8 homomer
(pH optimum 7.5 and 8.0, respectively) (10,12).
Interestingly, the primer extension activity of nsp(7+8)
did not require manganese ions as was previously reported
for the His-nsp8 homomer (12). In fact, similar to the
SARS-CoV nsp12-RdRp (10), the addition of Mn
2+ was
found to reduce the ﬁdelity of nsp(7+8) and induce both
transversional and transitional misincorporations in a
pulse–chase experiment (Figure 6E and F). Interestingly,
the assay also revealed a discrimination against the widely
Figure 5. Mutagenesis of SARS-CoV nsp8. (A) Alignment of nsp8 sequences from representative alpha-, beta- and gammacoronaviruses. Fully
conserved residues are shaded red, while partially conserved residues are boxed. The residues targeted by mutagenesis are indicated with asterisks.
Please see ‘Material and Methods’ section for the Genbank accession numbers associated with the presented sequences. (B) To verify that the
observed extension activity was nsp8-dependent, we tested the incorporation of AMP into the primed U20 template by 1, 5 or 10mM of wild-type
nsp8 or template-binding mutant K58A. Mutation of K58 resulted in a  95% reduction of AMP incorporation. (C) To assess the importance of the
two D/ExD/E motifs in nsp8, we engineered alanine substitution mutants of these residues and tested their primer extension activity on the primed
UC10 template (see Figure 4). Reactions were stopped after 60min and compared to the activity of the wild-type nsp(7+8) complex on a 20% PAGE/
7M urea gel. The bottom panel shows the nsp8 protein concentration present in each of the reactions. (D) Quantiﬁcation of the primer extension
activities on the CU10 template of the D/ExD/E alanine substitution mutants and control substitutions K58A and K127A. Values are normalized to
the protein concentration. Error bars represent standard deviations (n=3).
Nucleic Acids Research,2012, Vol.40, No. 4 1743used ATP and GTP analogue ribavirin triphosphate
(RTP) (24,25). Whether this may offer an explanation
for SARS-CoV’s relative resistance to this antiviral drug
(26,27) remains an open question for future research.
N-terminal extensions other than nsp7 frustrate the primer
extension activity of nsp8
The primer-extension and terminal transferase activity
documented in Figure 4 for the complex containing the
untagged nsp8 was not observed by Imbert et al. (12)
when they ﬁrst puriﬁed and analysed His-nsp8. To inves-
tigate whether this difference could be attributed to
complex formation with nsp7 or the removal of the
afﬁnity tag, we performed the primer extension assay
with three different recombinant nsp8 versions of which
the gel ﬁltration analysis is documented in Figure 2.
Interestingly, for all three variants primer-extension
activity was observed (Figure 7A), but the activity was
most pronounced for nsp8-His and the untagged nsp8
(Figure 7A). To estimate the effect of nsp7 on the
nsp8-driven primer extension activity, we performed a
direct comparison of the two enzyme complexes and
found that the activity of nsp8 alone was >2-fold lower
than when nsp7 and nsp8 were present at equal molarity in
the reaction (Figures 4D and 7B). A similar comparison
was performed for the de novo activity of nsp8, using the
assay published by Imbert et al. (12) and taking the ﬁrst
dinucleotide (pppGpA) product as readout. Interestingly,
both nsp8 and nsp(7+8) synthesized equal amounts of the
pppGpA dinucleotide (Figure 7C), suggesting that the
effect of nsp8 is limited to the primer-extension activity
of nsp8. In addition, we observed that the de novo initi-
ation activity of nsp8 was  2-fold higher than that of
His-nsp8 (Figure 7D).
Our comparative study revealed that the N-terminal
His6-tag of His-nsp8 greatly inﬂuences the primer-
extension activity of nsp8 (Figure 7A), its multimerization
proﬁle and its association with nsp7 (Figure 2). To test if
this inhibitory effect was His6-tag speciﬁc, we assessed the
activity of a ub-nsp8-His fusion protein. At the same time,
control reactions were performed in which we (i) followed
the activity of this protein as it was being processed by a
recombinant form of the ubiquitin-cleaving nsp2 protease
of equine arteritis virus (28) or (ii) monitored the activity
of nsp8-His. As shown in Supplementary Figure S3, the
presence of the ub-tag decreased nsp8 activity to a level
that was comparable to that of N-terminally His6-tagged
nsp8. Upon cleavage by EAV nsp2, however, a partial
recovery of the primer extension activity was observed
(Supplementary Figure S3). Unfortunately, we were not
able to perform the same experiment with puriﬁed
ub-nsp8, since our recombinant nsp5 removed the
N-terminal ub-tag with similar efﬁciency as the
C-terminal His6-tag (Supplementary Figure S4).
Extrapolating to the situation in the viral pp1a and
pp1ab precursor polyproteins, in which the nsp8
N-terminus is initially fused to nsp7 (Figure 1A), our ob-
servations suggested that nsp8 may thus be inactive in the
polyprotein context. This would constitute a form of regu-
lation of viral enzyme activity that is not without
Figure 6. Inﬂuence of divalent ions and pH on nsp(7+8) activity.
(A) To test the inﬂuence of magnesium ions on nsp(7+8) activity, we
performed nsp(7+8) primer extension reactions at 0–10mM Mg
2+.
(B) Quantiﬁcation of the results presented in Figure 6A, presented as
the amount of NTP incorporated permM nsp8 monomer. Error bars
represent standard deviations (n=3). (C) The inﬂuence of the pH on
nsp(7+8) activity was tested for a pH range of 6–11. A clear optimum
was observed around 9.5. (D) Quantiﬁcation of the results in
Figure 6C, presented as the amount of NTP incorporated permM
nsp8 monomer. Error bars indicate standard deviations (n=3).
(E) Schematic presentation of the pulse-chase experiment that was
used to test the nsp(7+8) nucleotide incorporation speciﬁcity on a
primed poly(U) template (see Table 1). The reactions were initiated
with a limiting concentration of [a-
32P]ATP to allow the formation of
a stable polymerase-template complex. Unlabelled nucleotides were
used at a ﬁnal concentration of 50mM. (F) SARS-CoV nsp(7+8)
allowed only limited transversional and transitional mutations. Use of
manganese ions as cofactor for polymerase activity resulted in a minor,
though noticeable loss of ﬁdelity. Lane 1 represents the input signal to
which no unlabelled nucleotides were added. Nucleoside triphosphates
are abbreviated to single letters (i.e. A for ATP, G for GTP, U for
UTP, C for CTP and R for RTP).
1744 Nucleic Acids Research, 2012,Vol.40, No. 4precedent, since also the poliovirus 3Dpol is inactive as
long as it is fused to the 3C protease in the 3CD precursor
(29). To verify this hypothesis, we expressed nsp7-8-His
and tested this protein for RdRp activity. Interestingly,
this fusion protein, a potential intermediate of CoV rep-
licase polyprotein processing and a multimer in solution
(Figure 7E), showed primer extension activities that were
comparable to or higher than the activity of nsp(7+8-His)
(Figure 7F). The de novo initiation activity of nsp7-8-His
was, however,  2-fold lower than the activity of nsp8 and
nsp(7+8) (Figure 7D). In conclusion, this result clearly
underlines that the two N-terminal fusion partners other
than nsp7 are speciﬁcally detrimental to SARS-CoV nsp8
primer-dependent RdRp activity in vitro. It also demon-
strates that nsp8 alone may be sufﬁcient to act as a
primase.
DISCUSSION
The complex replication and transcription process that
coronaviruses initiate upon infection involves up to 16
viral nsps and at least one host factor (30–32). Both indi-
vidually as well as in complex with each other, these
subunits engage in numerous protein–protein interactions
(17,33) and embody various enzymatic activities, including
proteolytic (19,34), ATPase (35), and 50 cap modifying
reactions (36). Remarkably though, the mechanism and
enzymes required to catalyse RNA synthesis in the CoV
RTC remain very poorly understood. Moreover, uniquely
among RNA viruses which generally employ a single
RNA polymerase to drive their RNA synthesis (1,2), the
polymerase activity assays and nsp8 mutagenesis docu-
mented in this and other studies suggest that, in addition
to the presumed nsp12 ‘main RdRp’, other polymerase
activities could play a critical role in the synthesis of
SARS-CoV RNAs (10,12,37,38).
Following up on the description of an nsp8- and
nsp7-containing hexadecameric ring structure (13) and
the nsp8-associated polymerase activity (12), we here dem-
onstrate that the nsp(7+8) hexadecamer is the most
probable conformation of the second SARS-CoV poly-
merase, given the near-complete association of nsp7 and
nsp8 when mixed 1:1 in solution (Figure 2F). Signiﬁcant
for our understanding of CoV RNA synthesis, we ﬁnd
that this complex is capable of binding dsRNA molecules
and extending partially double-stranded RNA templates.
This activity is therefore essentially comparable to the
activity reported for the nsp12-RdRp (10).
A direct comparison with the nsp12 activity is difﬁcult,
however. In the course of a one-hour reaction, 0.1mM
monomeric nsp12-RdRp incorporates  2mM NMP into
a primed (CU)10 template (10). The nsp(7+8) complex, at
a1 mM concentration of nsp7 and nsp8 monomers, in-
corporates  1mM NMP. Per monomer, the activity dif-
ference is therefore 20-fold, but if we assume that most
nsp7 and nsp8 monomers assemble into hexadecamers and
that each hexadecamer contributes only one functional
active site per incorporation event, the difference would
be much smaller and only  2.5-fold. Presently, however,
we do not yet have an estimate for the efﬁciency and sta-
bility of the nsp(7+8) complex, nor do we know the
number of active sites in the complex that determine its
overall activity.
Mutagenesis of nsp8 was performed to identify residues
that may contribute to the catalytic centre of the nsp(7+8)
polymerase, while differently tagged nsp8 recombinant
proteins were constructed to explain some striking differ-
ences with previous observations. These efforts resulted in
two intriguing observations. Firstly, mutation of the
conserved N-terminal D/ExD/E motif, comprising D50
Figure 7. Inﬂuence of His6-tags and nsp7 on the RdRp activity of
SARS-CoV nsp8. (A) The UC10 template (see Figure 4) was incubated
with 1mM of wild-type nsp8 or either of three nsp8 variants to inves-
tigate the inﬂuence of the His6-tag. Samples were taken at the indicated
time points and checked for [a-
32P]AMP incorporation by 20% PAGE/
7M urea analysis. (B) Side-by-side comparison of the primer-extension
activities of nps8 and nsp(7+8). Shorter incubations are shown to better
demonstrate the difference in activity. (C) De novo activity of nsp8 and
nsp(7+8) on template AFMB131 (see Table 1), using the synthesis of
the ﬁrst dinucleotide pppGpA, as previously described by Imbert et al.
(12), as readout. Nsp8 template binding mutant K58A was used as
negative control. The AMP contaminant present in the used
[a-
32P]ATP label is marked as loading control and size reference.
(D) Side-by-side comparison of the de novo initiation activities of
nps8, His-nsp8 and nsp7-8-His. (E) Elution proﬁle of the nsp7-8-His
fusion protein relative to nsp8-His. (F) Primer-extension activities
of putative cleavage intermediate nsp7-8 on the U20 template (see
Figure 4 and Table 1).
Nucleic Acids Research,2012, Vol.40, No. 4 1745and D52 in SARS-CoV, abolished RdRp activity, whereas
mutation of the C-terminal motif, including SARS-CoV
residues D161 and D163, did not affect polymerase
activity (Figure 5). Given the general importance of
acidic residues for metal–ion coordination in polymerase
active sites (3–5,22) and the D/ExD/E consensus sequence
in coronaviruses at positions 50–52, we now postulate that
these residues are part of the Mg
2+-binding active site in
spite of the more conserved nature of D161 and D163
(Figure 5), and their position in the nsp(7+8) structure
(see below for further discussion).
Secondly, the presence of N-terminal extensions other
than nsp7, such as ubiquitin and His6, severely affected the
primer extension activity of nsp8 (Figure 7), potentially by
changing its oligomeric state (Figure 2). However, the
relatively strong activity of nsp7-8 (Figure 7), a potential
naturally occurring replicase processing intermediate,
implies that nsp8’s activity is unlikely to be directly
controlled by an N-terminal cleavage event, as was
observed for, e.g. the poliovirus polymerase (29). In
addition, these observations suggest that a more diverse
array of nsp8-containing RdRps may be involved in CoV
replication and transcription.
Comparing our data against the background of the
previously published nsp(7+8) structure (13), we made
four main observations. Firstly, we note that in the pub-
lished nsp(7+8) crystal structure four of the eight
N-terminal D/ExD/E motifs in the complex reside at the
border of partially unresolved N-terminal nsp8 domains,
where the coordinates of up to 49 nsp8 residues and 5
exogenous amino acids derived from the removed GST
fusion partner were not determined. In light of our own
ﬁnding that unnatural N-terminal extensions severely
impair nsp8’s RdRp activity (Figure 5), this suggests
that the published crystal structure may not represent an
active conformation of the nsp(7+8) polymerase.
Secondly, we observe that residues D50 and D52, which
are both crucial for nsp(7+8) activity, are residing in an
a-helix in the nsp(7+8) structure (Supplementary Figure
S5), whereas in canonical primases and polymerases, the
catalytic centre is preferentially located on b-strands or
turns (12,22). Thirdly, we note that Mg
2+ was lacking
from the published nsp(7+8) crystal structure (13), even
though it is required for nsp(7+8) activity. Fourthly and
last, we observe that a 1:1 ratio of nsp7:nsp8 is sufﬁcient to
capture all nsp8 in a higher molecular weight complex
(Figure 2F) whereas previously a 2:1 ratio was required
(13), potentially due to the additional N-terminal residues
that altered the dynamics of complex formation.
The (functional) implications of these observations are
not clear at present, but additional structural studies will
likely be required to address these issues in detail, and gain
insights that may aid in explaining the in vitro results pre-
sented here. Likely, such experiments will also offer
further information regarding the residues that are
involved in nucleotide positioning, Mg
2+ coordination
and RdRp chemistry.
In summary, our results provide important novel
insights into the functionality of the SARS-CoV
hexadecameric nsp(7+8) complex and demonstrate its
activity as an RNA polymerase. In addition, our
experiments and controls revealed and address a number
of disparities between previous claims and hypotheses
(12), and our own observations. The ‘primase hypothesis’
previously formulated by Imbert and co-workers (12)
remains an intriguing model to explain the initiation of
SARS-CoV RNA synthesis and is a topic that will be ad-
dressed in detail elsewhere. Nevertheless, based on the
primer extension activity of nsp(7+8) on non-structured
RNA templates, we can no longer exclude the possibility
that nsp(7+8) may synthesise substantially longer
products than mere oligonucleotide primers in vivo,
possibly stimulated by the presence of additional viral
protein factors that could e.g. provide RNA-unwinding
activity. Consequently, it is now a distinct possibility
that CoV RNA synthesis involves structurally different
and functionally separable RNA synthesising complexes
[e.g. containing nsp12 or nsp(7+8)], each possessing their
own dedicated RdRp characteristics and function in viral
plus or minus strand RNA synthesis. It will therefore be
crucial to study whether these different polymerase
activities are part of the same enzyme complex and, if
so, whether they can inﬂuence each other’s activity or
are subject to additional control mechanisms.
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